Adrhim Pharmaceuticals LLP
About Adrhim Pharmaceuticals LLP
Data last updated:
Adrhim Pharmaceuticals LLP is a limited liability partnership (LLP) based in Gandhinagar, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 April 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAJ-0957. Its GSTIN is 24ABIFA0185F1ZS (Gujarat).
The LLP has a total obligation of contribution of ₹2 Cr. It is led by designated partners Himanshukumar Ishvarlal Patel and Dineshkumar Dwarkadas Patel.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Survey No.243 Nera Gayatri Dairy Bileshwarpura Kalol, Gandhinagar, Gujarat, India – 382721.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹15.5 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹76.05 Lakh (net margin 4.9%) and EBITDA of ₹1.02 Cr (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 187% over three years.
The LLP has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹8.48 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSurvey No.243 Nera Gayatri Dairy Bileshwarpura Kalol, Gandhinagar, Gujarat, India – 382721
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Adrhim Pharmaceuticals LLP FY 2025 filings available
Adrhim Pharmaceuticals LLP reported revenue of ₹15.5 Cr (up 190% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Adrhim Pharmaceuticals LLP
Revenue has grown at a compounded annual rate (CAGR) of 187% over three years, including 190% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Adrhim Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹15.5 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹76.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Adrhim Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Adrhim Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Adrhim Pharmaceuticals LLP
Adrhim Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshukumar Ishvarlal Patel | Designated Partner | 07 Apr 2017 | 9 Years 6 Months | Current |
| Dineshkumar Dwarkadas Patel | Designated Partner | 07 Apr 2017 | 9 Years 6 Months | Current |
Ownership and Shareholding of Adrhim Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Adrhim Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2025 | Sidbi | ₹1.54 Cr | Open |
| 18 Mar 2025 | Sidbi | ₹1.6 Cr | Open |
| 12 Oct 2021 | Sidbi | ₹2.5 Cr | Open |
| 24 Jul 2019 | Small Industries Development Bank of India | ₹2.84 Cr | Open |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Adrhim Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Adrhim Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Adrhim Pharmaceuticals LLP
Adrhim Pharmaceuticals LLP has 3 designated partner changes on record since 2017: 2 appointments and 1 cessation. The latest: Mayankkumar Ishwarlal Patel ceased to be Designated Partner on 01 Apr 2018.
Credit Ratings, Litigation & Regulatory Alerts for Adrhim Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Adrhim Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Adrhim Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Adrhim Pharmaceuticals LLP
Adrhim Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABIFA0185F1ZS | Gujarat | Active | 05 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Adrhim Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adrhim Pharmaceuticals LLP
Adrhim Pharmaceuticals is an active limited liability partnership based in Gandhinagar, Gujarat, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 07 April 2017 (9+ years old) and is registered under LLPIN AAJ-0957.
Adrhim Pharmaceuticals reported revenue of ₹15.5 Cr for FY 2023 (up 190% YoY).
Adrhim Pharmaceuticals has 2 current designated partners:
- Himanshukumar Ishvarlal Patel - Designated Partner
- Dineshkumar Dwarkadas Patel - Designated Partner
Adrhim Pharmaceuticals reported a net profit of ₹76.05 Lakh (net margin 4.9%) and EBITDA of ₹1.02 Cr (EBITDA margin 6.6%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Adrhim Pharmaceuticals is 187% over three years. In the latest year (FY 2023) revenue rose 190%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Adrhim Pharmaceuticals is 24ABIFA0185F1ZS, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Adrhim Pharmaceuticals is AAJ-0957. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Adrhim Pharmaceuticals was incorporated on 07 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Mayankkumar Ishwarlal Patel ceased to be Designated Partner on 01 Apr 2018. Dineshkumar Dwarkadas Patel was appointed as Designated Partner on 07 Apr 2017. Himanshukumar Ishvarlal Patel was appointed as Designated Partner on 07 Apr 2017.
The registered office of Adrhim Pharmaceuticals is at Survey No.243 Nera Gayatri Dairy Bileshwarpura Kalol, Gandhinagar, Gujarat, India – 382721.